Region-exclusive distribution partnerships built on consistent supply and recurring economics.

Qualified distributor partnerships are commercial relationships beyond simple wholesale buying. The qualification process covers: market-presence verification in the destination region (existing customer base, regulatory licensing for the relevant product categories, established sales infrastructure), regulatory-compliance posture (the distributor must be able to support the destination market's regulatory requirements without dependency on PeptideXpo for compliance work), and volume commitment (typically a 12-month forward forecast at agreed minimum quantities). In exchange, qualified partners receive tiered pricing, region-exclusivity options, forecast-based inventory, OEM service access, and marketing collateral support.

Region-exclusivity is granted by country or multi-country market block and by product line. For the major regions, EU, SEA (Southeast Asia), LATAM (Latin America), MENA (Middle East and North Africa), and parts of APAC, exclusive distribution partnerships are currently available for qualified buyers in most product categories. The US market operates under a different model because of the compounding-pharmacy and 503B regulatory landscape, exclusive distribution to a single US partner is not generally offered. Discuss your region and product-line interest at quote stage; the regulatory team can describe the current exclusivity availability for your specific case.

Distributor partners receive: product-spec sheets for each catalog SKU (PDF format, brandable to distributor logo), sample COA examples for buyer-facing demonstrations, technical FAQ documentation for the most-asked questions in your region's downstream customer base, OEM brochure and finished-product capability deck, and on-call regulatory advisory for destination-market questions your downstream customers raise. The marketing collateral is updated quarterly to reflect catalog and regulatory changes. For the largest distributor partners, custom collateral development (region-specific case studies, localized product positioning) is part of the partnership agreement.

Drop-ship is available for some product categories but is not generally the recommended distributor model. Drop-shipping works for low-volume specialty SKUs (Khavinson bioregulators, reference-code products, custom-blend orders) where the distributor's value-add is regional sales presence rather than inventory provision. For high-volume catalog SKUs (GLP-1 class, repair peptides, cosmetic peptides), inventory-holding distributors deliver substantially better customer experience because lead times compress from the standard 7-21 days to in-region delivery. The pricing also differs, inventory-holding distributors price into more favorable tiers because they're committing capital alongside the partnership.

Heavily-regulated biologicals require destination-market import authorization, end-user licensing verification, and chain-of-custody documentation throughout the supply chain. Distributors carrying these categories must demonstrate appropriate licensing in their region before partnership qualification, the standard distributor partnership does not automatically extend to these product categories. For qualified partners with the appropriate licensing, separate documentation chains and compliance review apply to each order in these categories. The compliance overhead is meaningfully higher than for catalog research peptides; distributors should plan their regional product mix accordingly.